Voting rights on 30 September 2022
- 10 October 2022 - 1 mins read
This article or press release has no online content. Please download the associated documents for more information.
Attachment
14 November 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2023
13 November 2023
11 mins read
Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England...
07 November 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2023
06 November 2023
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
26 October 2023
7 mins read
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
24 October 2023
1 mins read
IPSEN – Buy-back program – Art 5 of MAR – Week 42 – 2023
23 October 2023
8 mins read
Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome
17 October 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2023
10 October 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2023
06 October 2023
1 mins read